Olefin metathesis route to antiviral nucleosides

Current Topics in Medicinal Chemistry

Volumn 5, Issue 15, 2005, Pages 1541-1558

  Agrofoglio, Luigi A ^a   Nolan, Steven P ^b  

^a Université d'Orléans   (France)

^b UNIVERSITY OF NEW ORLEANS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [(2 HYDROXYETHOXY)METHYL] 6 (PHENYLTHIO)THYMINE; 3 DEAZA NEPLANOCIN A; 9 (2',3' DIHYDROXYCYCLOPENT 4' ENYL) 3 DEAZAADENINE; 9 (2',3' DIHYDROXYCYCLOPENT 4' ENYL)ADENINE; ABACAVIR; ACICLOVIR; ADEFOVIR; ALKENE DERIVATIVE; ANTIVIRUS AGENT; ARISTEROMYCIN; CARBOVIR; CIDOFOVIR; CYCLOPENTENONE; CYTIDINE DERIVATIVE; DIDANOSINE; GANCICLOVIR; LAMIVUDINE; NEPLANOCIN A; NEPLANOCIN DERIVATIVE; NUCLEOSIDE DERIVATIVE; RUTHENIUM; STAVUDINE; UNCLASSIFIED DRUG; VALACICLOVIR; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; BENZYLATION; CATALYST; CELL VIABILITY; CROSS COUPLING REACTION; CYCLIZATION; CYTOTOXICITY; DEMETHYLATION; DRUG ABSORPTION; DRUG STRUCTURE; DRUG SYNTHESIS; HERPES SIMPLEX; HERPES ZOSTER; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; NONHUMAN; REVIEW; RING CLOSING METATHESIS; SIDE EFFECT; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SUBSTITUTION REACTION;

ALKENES; ANTIVIRAL AGENTS; CATALYSIS; CYCLIZATION; MOLECULAR STRUCTURE; MOLYBDENUM; NUCLEOSIDES; ORGANOMETALLIC COMPOUNDS; RUTHENIUM; STEREOISOMERISM;

EID: 29744456209     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802605775009739     Document Type: Review

References (126)

1. Reviews on applications of RCM: (a) Grubbs, R. H.; Miller, S. J.; Fu, G. C. Ring-closing Metathesis and Related Processes in Organic Synthesis. Acc. Chem. Res. 1995, 28, 446-452.
2. (b) Schmalz, H.-G. Catalytic Ring-closing Metathesis: A New, Powerful Technique for Carbon-carbon Coupling in Organic Synthesis. Angew. Chem., Int. Ed. Engl. 1995, 34, 1833-1936.
3. (c) Schuster, M.; Blechert, S. Olefin Metathesis in Organic Chemistry. Angew. Chem., Int. Ed. Engl. 1997, 36, 2036-2056.
4. (d) Grubbs, R. H.; Chang, S. Recent Advances in Olefin Metathesis and its Application in Organic Synthesis. Tetrahedron 1998, 54, 4413-4450.
5. (e) Grubbs, R. H. Olefin Metathesis Tetrahedron 2004, 60, 7117-7140.
6. (f) Schrock, R. R. Olefin Metathesis by Molybdenum Imido Alkylidene Catalysts. Tetrahedron 1999, 55, 8141-8153.
7. 2Ru=CHR Olefin Metathesis Catalysts: an Organometallic Success Story. Acc. Chem. Res. 2001, 34, 18-29.
8. Amblard, F.; Nolan, S. P.; Agrofoglio, L. A. Methathesis Strategy in Nucleoside Chemistry. Tetrahedron 2005, 61, 7067-7080.
9. Schrock, R.R.; Murdzek, J. S.; Bazan, G. C.; Robbins, J.; DiMare, M.; O'Regan, M. Synthesis of Molybdenum Imido Alkylidene Complexes and Some Reactions Involving Acyclic Olefins. J. Am. Chem. Soc. 1990, 112, 3875-3886.
10. (a) Fu, G. C.; Grubbs, R. H. The Application of Catalytic Ring-closing Olefin Metathesis to the Synthesis of Unsaturated Oxygen Heterocycles. J. Am. Chem. Soc. 1992, 114, 5426-5427.
11. (b) Fu, G. C.; Nguyen, S. T.; Grubbs, R. H. Catalytic Ring-closing Metathesis of Functionalized Dienes by a Ruthenium Carbene Complex. J. Am. Chem. Soc. 1993, 115, 9856-9857.
12. (c) Scholl, M.; Trnka, T. M.; Morgan, J. P.; Grubbs, R. H. Increased Ring Closing Metathesis Activity of Ruthenium-based Olefin Metathesis Catalysts Coordinated with Imidazolin-2-ylidene Ligands. Tetrahedron Lett. 1999, 40, 2247-2250.
13. (a) Kingsbury, J. S.; Harrity, J. P. A.; Bonitatebus, P. J., Jr.; Hoveyda, A. H. A Recyclable Ru-Based Metathesis Catalyst. J. Am. Chem. Soc. 1999, 121, 791-799.
14. (b) Harrity, J. P. A.; Visser, M. S.; Gleason, J. D.; Hoveyda, A. H. Ru-Catalyzed Rearrangement of Styrenyl Ethers. Enantioselective Synthesis of Chromenes through Zr- and Ru-Catalyzed Processes. J. Am. Chem. Soc. 1997, 119, 1488-1489.
15. Garber, S. B.; Kingsbury, J. S.; Gray, B. L.; Hoveyda, A. H. Efficient and Recyclable Monomeric and Dendritic Ru-Based Metathesis Catalysts. J. Am. Chem. Soc. 2000, 122, 8168-8179.
16. Huang, J.; Stevens, E. D.; Nolan, S. P.; Peterson, J. L. Olefin Metathesis-active Ruthenium Complexes Bearing a Nucleophilic Carbene Ligand. J. Am. Chem. Soc. 1999, 121, 2674-2678
17. Borchardt, R.; Keller, B.; Patel-Thrombe, U. Neplanocin A. A Potent Inhibitor of S-adenosylhomocysteine Hydrolase and of Vaccinia Virus Multiplication in Mouse L929 cells. J. Biol. Chem. 1984, 259, 4353-4358.
18. (a) Barbosa, E.; Moss, B. mRNA(nucleoside-2′-)-methyltransferase from Vaccinia Virus. Characteristics and Substrate Specificity. J. Biol. Chem. 1978, 253, 7698-7702.
19. (b) Bader, J. P.; Brown, N. R.; Chiang, P. K.; Cantoni, G. L. 3-Deazaadenosine, an Inhibitor of Adenosylhomocysteine Hydrolase, Inhibits Reproduction of Rous Sarcoma Virus and Transformation of Chick Embryo Cells. Virology 1978, 89, 494-505.
20. Hasobe, M.; McKee, J. G.; Borcherding, D. R.; Keller, B. T.; Borchardt, R. T. Effects of 9-(trans-2′,trans-3′- dihydroxycyclopent-4′-enyl)-adenine and -3-Deazaadenine on the Metabolism of S-adenosylhomocysteine in Mouse L929 cells. Mol. Pharmacol. 1988, 33, 713-720.
21. De Clercq, E. Antiviral and Antimetabolic Activities of Neplanocins. Antimicrob. Agents Chemother. 1985, 28, 84-89
22. (a) Glazer, R. I.; Knode, M. C. Neplanocin A. A Cyclopentene Analog of Adenosine with Specificity for Inhibiting RNA Methylation. J. Biol. Chem. 1984, 259, 12964-12969.
23. (b) Inaba, M.; Nagashima, S.; Tsukagoshi, S.; Sakurai, Y. Biochemical Mode of Cytotoxic Action of Neplanocin A in L1210 leukemic cells. Cancer Res. 1986, 46, 1063-1067.
24. (a) Shuto, S.; Obara, T.; Torija, M.; Hosoya, M.; Snoeck, R.; Andrei, G.; Balzarini, J.; De Clercq, E. New neplanocin analogs. 1. Synthesis of 6′-Modified Neplanocin A Derivatives as Broad-spectrum Antiviral Agents. J. Med. Chem. 1992, 35, 324-331.
25. (b) Shigeta, S.; Mori, S.; Baba, M.; Ito, M.; Honzumi, K.; Nakamura, K.; Oshitani, H.; Numazaki, Y.; Matsuda, A.; Obara, T.; Shuto, S.; De Clercq, E. Antiviral Activities of Ribavirin, 5-Ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6′-(R)-6′-C-methylneplanocin A against several Ortho- and Paramyxoviruses. Antimicrob. Agents Chemother. 1992, 36, 435-439.
26. (c) Shuto, S.; Obara, T.; Kosugi, Y.; Toriya, M.; Yaginuma, S.; Shigeta, S.; Matsuda, A. New Neplanocin Analogues. III. 6′ R-configuration is Essential for the Antiviral Activity of 6′-C-methyl-3-deazaneplanocin A's. Biomed. Chem. Lett. 1994, 4, 605-608.
27. (d) Shuto, S.; Obara, T.; Saito, Y.; Andrei, G.; Snoeck, R.; De Clercq, E. New Neplanocin Analogues. 6. Synthesis and Potent Antiviral Activity of 6′-Homoneplanocin A. J. Med. Chem. 1996, 39, 2392-2399.
28. (a) Borcherding, D. R.; Narayanan, S.; Hasobe, M.; McKee, J. G.; Keller, B. T.; Borchardt, R. T. Potential Inhibitors of S-adenosylmethionine-dependent Methyltransferases. 11. Molecular Dissections of Neplanocin A as Potential Inhibitors of S-adenosylhomocysteine Hydrolase. J. Med. Chem. 1988, 31, 1729-1738.
29. (b) Tseng, C. K. H.; Marquez, V. E.; Fuller, R. W.; Goldstein, B. M.; Haines, D. R.; McPherson, H.; Parsons, J. L.; Shannon, W. M.; Arnett, G.; Hollingshead, M.; Driscoll, J. Synthesis of 3-Deazaneplanocin A, a Powerful Inhibitor of S-adenosylhomocysteine Hydrolase with Potent and Selective in vitro and in vivo Antiviral activities. J. Med. Chem. 1989, 32, 1442-1446.
30. (a) Lim, M.; Moyer, D.; Cysyk, R.; Marquez, V. Cyclopentenyluridine and Cyclopentenylcytidine Analogs as Inhibitors of Uridine-cytidine kinase. J. Med. Chem. 1984, 27, 1536-1538.
31. (b) Russ, P.; Hegedus, L.; Kelley, J.; Barchi, J.; Marquez, V. The Controlled Stereospecific Reduction of Cyclopentenyl Cytosine (CPE-C) to Carbodine and Isocarbodine. Nucleosides & Nucleotides 1992, 11, 351-363.
32. (c) Marquez, V.; Bodenteich, M. Psicoplanocin A. A Synthetic Carbocyclic Nucleoside with the Combined Structural Features of Neplanocin A and Psicofaranine. Nucleosides & Nucleotides 1991, 10, 311-314.
33. (d) Bodenteich, M.; Marquez, V. Synthesis of (±)-Psicoplanocin A.: A Carbocyclic Nucleoside Combining the Structural Features of Psicoflaranine and Neplanocin A. Tetrahedron Lett. 1990, 31, 5977-5980.
34. (e) S. Kim, S.; R. Fuller, R.; V. Marquez, V. Synthesis and Biological Activity of Ara- and 2′-deoxycyclopentenyl Cytosine Nucleoside Analogs. Nucleosides & Nucleotides 1990, 9, 663-677.
35. (f) Paisley, S.; Wolfe, M.; Borchardt, R. E-ring Deoxy Analogs of Etoposide. J. Med. Chem. 1989, 32, 1418-1420.
36. (g) Marquez, V.; Lim, M.; Treanor, S.; Plowman, J.; Priest, M.; Markovac, A.; Khan, M.; Kaskar, B.; Driscoll, J. Cyclopentenylcytosine. A Carbocyclic Nucleoside with Antitumor and Antiviral Properties. J. Med. Chem. 1988, 31, 1687-1694.
37. Arita, M.; Adachi, K.; Ito, Y.; Sawa, H.; Ohno, M. Enantioselective Synthesis of the Carbocyclic Nucleosides (-)-Aristeromycin and (-)-Neplanocin A by a Chemicoenzymatic Approach. J. Am. Chem. Soc. 1983, 105, 4049-4055.
38. Arai, Y.; Hayashi, Y.; Yamamoto, M.; Takayema, H.; Koizumi, T. An Enantioconvergent Route to Carbocyclic Nucleosides (-)-Aristeromycin and (-)-Neplanocin a via the Asymmetric Diels-Alder Reaction. J. Chem. Soc. Perkin Trans. 11988, 3133-3140.
39. (a) Vince, R.; Brownell, J.; Beers, S. A. 6-Deoxycarbovir: a xanthine oxidase activated prodrug of carbovir. Nucleosides Nucleotides 1995, 14, 39-44.
40. (b) Mashhood, S.; Ramesh, K.; Borchardt, R. Efficient Enantioselective Syntheses of Carbocyclic Nucleoside and Prostaglandin Synthons. Tetrahedron Lett. 1990, 31, 1509-1512.
41. (a) Trost, B. M.; Van Vranken, D. L. Asymmetric Transition Metal-catalyzed Allylic Alkylations. Chem. Rev. 1996, 96, 395-422.
42. (b) Trost, B. M. Designing a Receptor for Molecular Recognition in a Catalytic Synthetic Reaction: allylic alkylation. Acc. Chem. Res. 1996, 29, 355-364.
43. (c) Trost, B. M.; Madsen, R.; Guile, S. D. An Enantio- and Diastereo-controlled Synthesis of (-)-Neplanocin A and its 2,3-di-epi isomer. Tetrahedron Lett. 1997, 38, 1707-1710.
44. Agrofoglio, L. A.; Gillaizeau, I.; Saito, Y. Palladium-assisted Routes to Nucleosides. Chem. Rev. 2003, 103, 1875-1916.
45. (a) Gillaizeau, I.; Charamon, S.; Agrofoglio, L. A. Enantioselective Synthesis of Carba-L-furanose Precursors of Carbanucleosides, using Ring-closing Metathesis. Tetrahedron Lett. 2001, 42, 8817-8819.
46. (b) Agrofoglio, L. A.; Amblard, F.; Nolan, S. P.; Charamon, S.; Gillaizeau, I.; Zevaco, T. A.; Guenot, P. Synthesis of L-Cyclopentenyl Nucleosides using Ring-closing Metathesis and Palladium-mediated Allylic Alkylation Methodologies. Tetrahedron, 2004, 60, 8397-8404.
47. Jin, Y. H.; Liu, P.; Wang, J.; Baker, R.; Huggins, J.; Chu, C. K. Practical Synthesis of D- and L-2-Cyclopentenone and Their Utility for the Synthesis of Carbocyclic Antiviral Nucleosides against Orthopox Viruses (Smallpox, Monkeypox, and Cowpox Virus). J. Org. Chem. 2003, 68, 9012-9018.
48. Moon, H. R.; Kim, H. O.; Lee, K. M.; Chun, M. W.; Kim, J. H.; Jeong, L. S. Stereoselective Synthesis of a Novel Apio Analogue of Neplanocin A as Potential S-Adenosylhomocysteine Hydrolase Inhibitor. Org. Lett. 2002, 4, 3501-3503.
49. Lee, K.; Cass, C.; Jacobson, K. A. Synthesis Using Ring Closure Metathesis and Effect on Nucleoside Transport of a (N)-Methanocarba S-(4-Nitrobenzyl)thioinosine Derivative. Org. Lett. 2001, 3, 597-599.
50. a) Borchardt, R. T.; Wu, Y. S. Potential Inhibitors of S-Adenosylmethionine-dependent Methyltransferases. 1. Modification of the Amino Acid Portion of S-Adenosylhomocysteine. J. Med Chem. 1974, 17, 862-868.
51. (b) Pugh, C. S. G.; Borchardt, R. T. Effects of S-Adenosylhomocysteine Analogs on Vaccinia Viral mRNA Synthesis and Methylation. Biochemistry 1982, 21, 1535-1541.
52. (c) Houston, D. M.; Matuszewska, B.; Borchardt, R. T. Potential Inhibitors of S-Adenosylmethionine-Dependent Methyltransferases. 10. Base- and Amino Acid Modified Analogs of S-Aristeromycinyl-L-homocysteine. J. Med. Chem. 1985, 28, 478-482.
53. Houston, D. M.; Dolence, E. K.; Keller, B. T.; Patel-Thrombre, U.; Borchardt, R. T. Potential Inhibitors of S-Adenosylmethionine-dependent Methyltransferases. 9. 2′,3′-Dialdehyde Derivatives of Carbocyclic Purine Nucleosides as Inhibitors of S-adenosylhomocysteine hydrolase. J. Med. Chem. 1985, 28, 471-477.
54. Hasobe, M.; Liang, H.; Ault-Riche, D. B.; Borcherding, D. R.; Wolfe, M. S.; Borchardt, R. T. (1′R,2′S,3′R)-9-(2′, 3′-dihydroxycyclopentan-l′-yl)-adenine and -3-deaza-adenine: analogs of aristeromycin which exhibit potent antiviral activity with reduced cytotoxicity. Antiviral Chem. Chemother. 1993, 4, 245-248.
55. Patil, S. D.; Schneller, S. W.; Hosoya, M.; Snoeck, R.; Andrei, G.; Balzarini, J.; De Clercq, E. The Synthesis and Antiviral Properties of (±)-5′-Noraristeromycin and Related Purine Carbocyclic Nucleosides. A New Lead for Anti-human Cytomegalovirus agent design. J. Med. Chem. 1992, 35, 3372-3377.
56. Siddiqi, S. M.; Chen, X.; Schneller, S. W. An Epimer of 5′-Noraristeromycin and Its Antiviral Properties. J. Med. Chem. 1994, 37, 1382-1384.
57. (a) Shealy, Y.; Clayton, J. 9-[b-DL-2α,3α-Dihydroxy-4-(hydroxymethyl)- cyclopentyl]adenine, the Carbocyclic Analog of Adenosine. J. Am. Chem. Soc. 1966, 88, 3885-3887.
58. (b) Rosenquist, A.; Kvarnstrom, L; Svensson, S. C. T.; Classon, B.; Samuelsson, B. Synthesis of Carbocyclic 2′,3′-Dideoxy-2′-C-hydroxymethyl Nucleosides as Potential Inhibitors of HIV. J. Org. Chem. 1994, 59, 1779-1782.
59. (c) Borthwick, A. D.; Biggadike, K. Synthesis of Chiral Carbocyclic Nucleosides. Tetrahedron 1992, 48, 571-623.
60. (d) Agrofoglio, L.A.; Challand, S.R. in «Acyclic, Carbocyclic and L-Nucleosides». 1998, Dordrecht: Kluwer Academic Publishers.
61. (a) Bestmann, H. J.; Roth, D. Total Synthesis of (-)-Aristeromycin. Synlett 1990, 751-753.
62. (b) Borcherding, D. R.; Scholtz, S. A.; Borchardt, R. T. Synthesis of Analogs of Neplanocin A: Utilization of Optically Active Dihydroxycyclopentenones Derived from Carbohydrates. J. Org. Chem. 1987, 52, 5457-5761.
63. Choi, W. J.; Park, Yoo, S. J.; Kim, H. O.; Moon, H. R.; Chun, M. W.; Jung, Y. H.; Jeong, L. S. Syntheses of D- and L-Cyclopentenone Derivatives Using Ring-Closing Metathesis: Versatile Intermediates for the Synthesis of D- and L-Carbocyclic Nucleosides. J. Org. Chem. 2001, 66, 6490-6494.
64. (a) Moon, H. R.; Choi, W. J.; Kim, H. O.; Jeong, L. S. Improved and alternative synthesis of D- and L-Cyclopentenone Derivatives, the Versatile Intermediates for the Snthesis of Carbocyclic Nucleosides. Tetrahedron: Asym. 2002, 13, 1189-1193.
65. (b) Yang, M.; Ye, W.; Schneller, S. W. Preparation of Carbocyclic S-Adenosylazamethionine Accompanied by a Practical Synthesis of (-)-Aristeromycin. J. Org. Chem. 2004, 69, 3993-3996.
66. De Clercq, E. Toward Improved Anti-HIV Chemotherapy: Therapeutic Strategies for Intervention with HIV Infections. J. Med. Chem. 1995, 38, 2491-2517.
67. Crimmins, M. T. New Developments in the Enantioselective Synthesis of Cyclopentyl Carbocyclic Nucleosides. Tetrahedron 1998, 54, 9229-9272.
68. Huryn, D. M.; Okabe, M. AIDS-driven Nucleoside Chemistry. Chem. Rev. 1992, 92, 1745-1768.
69. (a) Kim, C.-H.; Marquez, V. E.; Broder, S.; Mitsuya, H.; Driscoll, J. S. Potential anti-AIDS Drugs. 2′,3′-Dideoxycytidine Analogs. J. Med. Chem. 1987, 30, 862-866.
70. (b) Herdewijn, P; Balzarini, J.; De Clercq, E.; Pauwels, R.; Baba, M.; Broder, S.; Vanderhaeghe, H. 3′-Substituted 2′,3′-Dideoxynucleoside Analogs as Potential Anti-HIV (HTLV-III/LAV) agents. J. Med. Chem. 1987, 30, 1270-1278.
71. Chu, C.K.; Bhadti, V.S.; Doboszewski, B.; Gu, Z.P.; Kosugi, Y.; Pullaiah, K.C.; Van Roey, P.V. General Syntheses of 2′,3′-Dideoxymicleosides and 2′,3′-Didehydro-2′,3′-Dideoxynucleosides. J. Org. Chem. 1989, 54, 2217-2225.
72. (a) Robins, M.J.; Hansske, F.; Low, N.H.; Park, J.I. A Mild Conversion of Vicinal Diols to Alkenes. Efficient Transformation of Ribonucleosides into 2-ene and 2′,3′-Dideoxynucleosides. Tetrahedron Lett. 1984, 25, 367-370.
73. (b) Robins, M.J.; Madej; D.; Low, N.H.; Hansske, F.; Zou, R. In Nucleic Acid Chemistry. Improved and New Synthetic Procedures, Methods, and Techniques; Townsend, L.B. Tipson, R.S., Eds.; Wiley: New York, 1991; Vol. 4, pp 211-219.
74. (c) Robins, M.J.; Wilson, J.S.; Madej, D.; Low, N.H.; Hansske, F.; Wnuk, S.F. Nucleic Acid-Related Compounds. 88. Efficient Conversions of Ribonucleosides into Their 2′,3′-Anhydro, 2′(and 3′)-Deoxy, 2′,3′-Didehydro-2′,3′-dideoxy, and 2′,3′-Dideoxynucleoside Analogs. J. Org. Chem. 1995, 60, 7902-7908.
75. (a) Clive, D.L; Wickens, P.L.; Sgarbi, P.W.M. Synthesis of 2′,3′-Didehydro-2′,3′-dideoxynucleosides by Reaction of 5′-Protected Nucleoside 2′,3′-Dimesylates with Telluride Dianion: A General Route from Cis Vicinal Diols to Olefins. J. Org. Chem. 1996, 61, 7426-7437.
76. (b) Clive, D.L.; Sgarbi, P.V.M.; Wickens, P.L. Synthesis of 2′,3′-Didehydro-2′,3′-dideoxynucleosides by Reaction of 5′-O-Protected Nucleoside 2′,3′-Dimesylates with Lithium Areneselenolates. J. Org. Chem. 1997, 62, 3751-3753.
77. Beach, J.W.; Kim, H.O.; Jeong, L.S.; Nampalli, S.; Islam, Q.; Ahn, S.K.; Babu, J.R.; Chu, C.K. A Highly Stereoselective Synthesis of Anti-HIV 2′,3′-Dideoxy- and 2′,3′-Didehydro-2′,3′-dideoxynucleosides. J. Org. Chem. 1992, 57, 3887-3894.
78. Díaz, Y.; El-Laghdach, A.; Matheu, I.; Castillón, S. Stereoselective Synthesis of 2′,3′-Dideoxynucleosides by Addition of Selenium Electrophiles to Glycals. A Formal Synthesis of D4T from 2-Deoxyribose. J. Org. Chem. 1997, 62, 1501-1505.
79. (a) Seepersaud, M.; Al-Abed, Y. Studies Directed Toward the Synthesis of Carba-D-arabinofuranose. Tetrahedron Lett. 2000, 41, 7801-7803.
80. (b) Ko, O. H.; Hong, J. H. Efficient Synthesis of Novel Carbocyclic Nucleosides via Sequential Claisen Rearrangement and Ring-closing metathesis. Tetrahedron Lett. 2002, 43, 6399-6402.
81. (c) Montembault, M.; Bourgougnon, N.; Lebreton, J. Synthesis of 4′-C, 3′-O Bicyclic Thymidine Analogues using Ring Closure metathesis. Tetrahedron Lett. 2002, 43, 8091-8094.
82. Gillaizeau, I.; Lagoja, I. M.; Nolan, S. P.; Aucagne, V.; Rozenski, J.; Herdewijn, P.; Agrofoglio, L. A. Straightforward Synthesis of Labeled and Unlabeled Pyrimidine d4Ns via 2′,3′-Diyne Seco Analogues through Olefin Metathesis Reactions. Eur. J. Org. Chem. 2003, 666-671.
83. Milecki, J. Specific Labelling of Nucleosides and Nucleotides with 13C and 15N. J. Label. Compd. Radiopharm. 2002, 45, 307-337.
84. Trost, B. M.; Brown, B. S.; McEachern, E. J.; Kuhn, O. Asymmetric Synthesis of Oxygen Heterocycles via Pd-catalyzed Dynamic Kinetic Asymmetric Transformations: Application to Nucleosides. Chem. Eur. J. 2003, 9, 4442-4451.
85. (a) Vince, R.; Hua, M.; Brownell, J.; Daluge, S.; Lee, F. C.; Shannon, W. M.; Lavelle, G. C.; Qualls, J.; Weislow, O. S.; Kiser, R.; Canonico, P. G.; Schultz, R. H.; Narayanan, V. L.; Mayo J. G.; Shoemaker, R. H.; Boyd, M. R. Potent and Selective Activity of a New Carbocyclic Nucleoside Analog (Carbovir: NSC 614846) against Human Immunodeficiency Virus In vitro. Biochem. Biophys. Res. Commun. 1988, 156, 1046-1053.
86. (b) Vince, R.; Hua, M. Synthesis and anti-HIV Activity of Carbocyclic 2′,3′-Didehydro-2′, 3′-dideoxy 2,6-disubstituted Purine Nucleosides. J. Med. Chem. 1990, 33, 17-21.
87. Coates, J.; Ingall, H.; Pearson, B.; Penn, C.; Storer, R.; Williamson, C.; Cameron, J. Carbovir: the (-)-Enantiomer is a Potent and Selective Antiviral Agent against Human Immunodeficiency Virus in vitro. Antiviral Res. 1991, 15, 161-168.
88. (a) Daluge, S. M.; Good, S. S.; Faletto, M. B.; Miller, W. H.; St. Clair, M. H.; Boone, L. R.; Tisdale, M.; Parry, N. R.; Reardon, J. E.; Dornsife, R. E.; Averett, D. R.; Krenitsky, T. A. 1592U89, a Novel Carbocyclic Nucleoside Analog with Potent, Selective Anti-Human Immunodeficiency Virus Activity. Antimicrob. Agents Chemother. 1997, 41, 1082-1093.
89. (b) Faletto, M.B.; Miller, W. H.; Garvey, E. P.; St. Clair, M. H.; Daluge, S. M.; Good, S. S. Unique Intracellular Activation of the Potent Anti-Human Immunodeficiency Virus Agent 1592U89. Antimicrob. Agents Chemother. 1997, 41, 1099-1107.
90. (c) Tisdale, M.; Alnadaf, T.; Cousens, D. Combination of Mutations in Human Immunodeficiency Virus type 1 Reverse Transcriptase Required for Resistance to the Carbocyclic Nucleoside 1592U89. Antimicrob. Agents Chemother. 1997, 41, 1094.
91. (d) Good, S. S.; Daluge, S. M.; Ching, S. V.; Ayers, K. M.; Mabony, M. B.; Faletto, B. A.; Dowin, B. A.; Owens, B. S.; Dornsife, R. E.; McDowell, J. A.; LaFon, S.; Symonds, W. T. 1592U89 Succinate - Preclinical Toxicological and Disposition Studies and Preliminary Clinical Pharmacokinetics. Antiviral Res. 1995, 26, A229.
92. Crimmins, M. T.; King, B. W. An Efficient Asymmetric Approch to Carbocyclic Nucleosides: Asymmetric Synthesis of 1592U89, a Potent Inhibitor of HIV Reverse Transcriptase. J. Org. Chem. 1996, 61, 4192-4193.
93. Crimmins, M. T.; King, B. W.; Zuercher, W. J.; Choy, A. An Efficient, General Asymmetric Synthesis of Carbocyclic Nucleosides: Application of an Asymmetric Aldol/Ring-Closing Metathesis Strategy. J. Org. Chem. 2000, 65, 8499-8509.
94. Banerjee, S.; Ghosh, S.; Sinha, S.; Ghosh, S. Convenient Route to Btoh Enantiomers of a Highly Functionalized Trans-Disubstituted Cyclopentene. Synthesis of the Carbocyclic Core of the Nucleoside BCA. J. Org. Chem. 2005, 70, 4199-4202.
95. Oh, C. H.; Hong, J. H. Synthesis and Antiviral Activities of Novel 2′,4′- or 3′,4′-Doubly Branched Carbocyclic Nucleosides as Potential Antiviral Agents. Arch. Pharm. Pharm. Med. Chem. 2004, 337, 457-463.
96. Ko, O. H.; Hong, J. H. Synthesis and Biological Evaluation of Novel 2′,3′,4′-Triply Branched Carbocyclic Nucleosides as Potential Antiviral Agents. Arch. Pharm. Pharm. Med. Chem. 2004, 337, 579-586.
97. Agrofoglio, L. A.; Challand, S. R. In «Acyclic, Carbocyclic and L-Nucleosides»; Kluwer Academic Publishers: Dordrecht, 1998.
98. (a) Chu, C. K.; Cutler, S. J. Chemistry and Antiviral Activities of Acyclonucleosides. J. Heterocycl. Chem. 1986, 23, 289-319.
99. (b) De Clercq, E.; Holy, A.; Rosenberg, I.; Sakuma, T.; Balzarini, J.; Maudgal, P. C. A Novel Selective Broad-spectrum anti-DNA Virus Agent. Nature 1986, 323, 464-467.
100. (c) Naesens, L.; Snoeck, R.; Andrei, G.; Balzarini, J.; Neyts, J.; De Clercq, E. HPMPC (cidofovir), PMEA (adefovir) and Related Acyclic Nucleoside Phosphonate Analogs: a Review of their Pharmacology and Clinical Potential in the Treatment of Viral Infections. Antiviral. Chem. Chemother. 1997, 8, 1-23.
101. Kelley, J. L.; Schaeffer, H. J. Purine Acyclic Nucleosides. Unambiguous Synthesis of Acyclovir via a Furazano[3,4-d]pyrimidine. J. Heterocyclic Chem. 1986, 23, 271-273.
102. (a) Robins, M. J.; Hatfield, P. W. Nucleic Acid Related Compounds. 37. Convenient and High-yield Syntheses of N-[(2-Hydroxyethoxy)methyl]heterocycles as "Acyclic Nucleoside" analogs. Can. J. Chem. 1982, 60, 547-553.
103. (b) Tyms, A. S.; Kenny, M.; Navé, J.-F. Synthesis and Antiviral Activity of Rigid Acyclonucleotide Analogs. Bioorg. Med. Chem. Lett. 1995, 5, 1275-1280.
104. Vorbrüggen, H.; Krolikiewicz, K.; Bennua, B. Nucleoside Syntheses. XXII. Nucleoside Synthesis with Trimethylsilyl triflate and Perchlorate as Catalysts. Chem. Ber. 1981, 114, 1234-1255.
105. Shiragami, H.; Kogushi, Y.; Tanaka, Y.; Takamatsu, S.; Uchida, Y.; Ineyama, T.; Izawa, K. Synthesis of 9-(2-hydroxyethoxymethyl)guanine (acyclovir) from Guanosine. Nucleosides Nucleotides 1995, 14, 337-340.
106. (a) McCormick, J. E.; McElhinney, R. S. Thio Sugars. Part 7. Secouridines with Amino Groups in the Carbohydrate Component: Intramolecular Addition across the 5,6-Double Bond, and Molecular Combination of 5-Fluorouracil and N-(2-Chloroethyl)- N-nitrosourea Residues. J. Chem. Res. 1981, 10, 310-311.
107. (b) McGee, D. P. C.; Martin, J. C. Acyclic Nucleoside Analogs: Methods for the Preparation of 2′,3′-Secoguanosine, 5′-Deoxy-2′,3′-secoguanosine, and (R,S)-9-[1-(2-Hydroxyethoxy)-2-hydroxyethyl]guanine. Can. J. Chem. 1986, 64, 1885-1889.
108. (c) Kumar, A.; Walker, R. T. The Chemistry of 2′,3′-Seconucleosides IV. Synthesis and Reactions of 3′-azido-2′,3′-dideoxy-2′,3′-Secothymidine and Related Analogues. Tetrahedron 1990, 46, 3101-3110.
109. (a) Amblard, F.; Nolan, S. P.; Schinazi, R. F.; Agrofoglio, L. A. Efficient Synthesis of Various Acycloalkenyl Derivatives of Pyrimidine using Cross-metathesis and Pd(0) Methodologies. Tetrahedron 2005, 61, 537-544.
110. (b) Amblard, F.; Nolan, S. P.; Gillaizeau, I.; Agrofoglio, L. A. A New Route to Acyclic Nucleosides via Palladium-mediated Allylic Alkylation and Cross-metathesis. Tetrahedron Lett. 2003, 44, 9177-9180.
111. (c) Amblard, F.; Aucagne, V.; Guenot, P.; Schinazi, R. F.; Agrofoglio, L. A. Synthesis and Antiviral Activity of Novel Acyclic Nucleosides in the 5-Alkynyl- and 6-Alkylfuro[2,3-d]pyrimidine series. Bioorg. Med. Chem. 2005, 13, 1239-1248.
112. Crowe, W. E.; Zhang, Z. J. Highly Selective Cross-metathesis of Terminal Olefins. J. Am. Chem. Soc. 1993, 115, 10998-10999.
113. Jaeger, V.; Schohe, R. Acyclic Stereocontrol in the Addition of g-Akylthio-allylboronates to Aldehydes. Tetrahedron 1984, 40, 2199-2210.
114. Burchardt, A.; Takanashi, T.; Takeuchi, U.; Haufe, G. Synthesis of a Fluorinated Analogue of Anticancer Active Ether Lipids. J. Org. Chem. 2001, 66, 2078-2084.
115. (a) Suzuki, A. Organoborates in New Synthetic Reactions. Acc. Chem. Res. 1982, 15, 178-184.
116. (b) Suzuki, A. Recent Advances in the Cross-coupling Reactions of Organoboron Derivatives with Organic Electrophiles, 1995-1998. J. Organomet. Chem. 1999, 576, 147-168.
117. (c) Miyaura, N.; Suzuki, A. Stereoselective Synthesis of Arylated (E)-alkenes by the Reaction of Alk-1-enylboranes with Aryl halides in the Presence of Palladium Catalyst. Chem. Commun. 1979, 866-867.
118. (d) Miyaura, N.; Yamada, K.; Suzuki, A. A New Stereospecific Cross-coupling by the Palladium-catalyzed Reaction of I-Alkenylboranes with 1-Alkenyl or 1-alkynyl halides. Tetrahedron Lett. 1979, 20, 3437-3440.
119. Schroeder, A.C.Bloch, A.; Perlman, J. L.; Bobek, M. Synthesis and Biological Evaluation of 6-Ethynyluracil, a Thiol-specific Alkylating Pyrimidine. J. Med. Chem. 1982, 25, 1255-1258.
120. Tanaka, H.; Takashima, H.; Ubasawa, M.; Sekiya, K.; Nitta, I.; Baba, M.; Shigeta, S.; Walker, R. T.; De Clercq, E.; Miyasaka, T. Structure-activity Relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine Analogs: Effect of Substitutions at the C-6 Phenyl ring and at the C-5 Position on anti-HIV-1 Activity. J. Med. Chem. 1992, 35, 337-345.
121. (a) Hobbs, J. B. Comprehensive Medicinal Chemistry; Sammes, P. G., vol. Ed.; Pergamon Press: Oxford, UK, 1990; Vol 2, pp 299-331.
122. (b) Jacobson, K. A. Comprehensive Medicinal Chemistry, Emmet J. C., vol. Ed.; Pergamon Press: Oxford, UK, 1990; Vol 3, pp 601-642.
123. Tanaka, H.; Baba, M.; Hayakawa, H.; Sakamaki, T.; Miyasaka, T.; Ubasawa, M.; Takashima, H.; Sekiya, K.; Nitta, I.; Shigeta, S.; Walker, R. T.; Balzarini, J.; De Clercq, E. A New Class of HIV-1 Specific 6-substituted Acyclouridine Derivatives: Synthesis and anti-HIV-1 Activity of 5- or 6-Substituted Analogs of 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). J. Med. Chem. 1991, 34, 349-357.
124. (a) De Clercq, E. in "Trends in Drug Research"; Claassen, V., Ed.; Elsevier: Amsterdam, 1990; pp 133.
125. (b) Votruba, I.; Travnicek, M.; Rosenberg, I.; Otmar, M.; Hrebabecky, H.; Holy, A. Inhibition of Avian Myeloblastosis Virus Reverse Transcriptase by Diphosphates of Acyclic Phosphonylmethyl Nucleotide Analogues. Antiviral. Res. 1990, 13, 287-293.
126. (c) De Clercq, E. Broad-spectrum anti-DNA Virus and Anti-retrovirus Activity of Phosphonylmethoxyalkylpurines and -Pyrimidines. Biochem. Pharmacol. 1991, 42, 963-972.